GlassScriptPhysician profile
Hamideh S Moayedpardazi
NPI 1386933240
$7,183.20
in general payments reported to CMS, 2019-2025
15 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,577 · 2020: $584 · 2021: $628 · 2022: $1,097 · 2023: $1,478 · 2024: $1,519 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,278 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,278.08 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,039.02 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $1,334.22 | 2022-2025 | |
| Alcon Vision LLC | $1,194.91 | 2019-2024 | Clareon, Rocklatan, Simbrinza |
| Allergan, INC. | $625.53 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $260.63 | 2023-2024 | Quatera 700, Callisto Eye |
| Nova Eye, INC. | $259.00 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $122.00 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $83.05 | 2022-2023 | Cequa, Xelpros |
| Horizon Therapeutics Plc | $37.55 | 2021-2022 | |
| Shire North American Group INC | $31.93 | 2019 | |
| Aerie Pharmaceuticals, INC. | $24.96 | 2019 | |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
| Thea Pharma INC. | $17.69 | 2023 | |
| New World Medical,INC. | $9.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamideh Moayedpardazi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.